misonidazole has been researched along with fluorouracil in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levin, VA | 1 |
| Cai, RM; Ding, L; Jin, XQ; Jin, YZ; Lu, WQ; Shen, ZF; Xu, JF; Xu, LM; Yang, JK | 1 |
| Bonomi, P; Faber, LP; Reddy, S | 1 |
| Hasegawa, R | 1 |
| Allen, J; Edwards, MS; Levin, VA; Ortega, J; Vestnys, P; Wara, WM | 1 |
| Martin, WM; McDermott, BJ; Murphy, RF; Van den Berg, HW | 1 |
| Breccia, A; Gattavecchia, E; Tonelli, D | 1 |
| Tannock, IF | 1 |
| Maxwell, RJ | 1 |
| Dachs, GU; Firth, JD; Harris, AL; Patterson, AV; Ratcliffe, PJ; Stratford, IJ; Townsend, KM | 1 |
| Hicks, RJ; Leong, T; Lim-Joon, D; Loi, S; Mackay, J; Michael, M; Mitchell, P; Mukesh, B; Ngan, SY; Rischin, D; Zalcberg, J | 1 |
| Haustermans, K; Lee, JA; Loeckx, D; Maes, F; Nuyts, J; Penninckx, F; Roels, S; Slagmolen, P; Stroobants, S | 1 |
| Chan, K; Fury, M; Humm, J; Lee, N; Ling, CC; Nehmeh, S; Schöder, H | 1 |
| Ali, S; Lanciano, R; Rose, PG; Stehman, FB; Whitney, CW | 1 |
| De Bruycker, S; Pauwels, P; Staelens, S; Stroobants, S; Van den Wyngaert, T; Vangestel, C; Wouters, A; Wyffels, L | 1 |
2 review(s) available for misonidazole and fluorouracil
| Article | Year |
|---|---|
Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Evaluation; Fluorouracil; Humans; Lung Neoplasms; Misonidazole; Neoplasm Metastasis; Prognosis; Radiotherapy; Radiotherapy Dosage; Survival Rate | 1990 |
New techniques in the pharmacokinetic analysis of cancer drugs. III. Nuclear magnetic resonance.
Topics: Antineoplastic Agents; Fluorouracil; Folic Acid; Humans; Magnetic Resonance Spectroscopy; Misonidazole; Neoplasms | 1993 |
2 trial(s) available for misonidazole and fluorouracil
| Article | Year |
|---|---|
Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Evaluation; Fluorouracil; Humans; Lung Neoplasms; Misonidazole; Neoplasm Metastasis; Prognosis; Radiotherapy; Radiotherapy Dosage; Survival Rate | 1990 |
Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Misonidazole; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Rectal Neoplasms; Treatment Outcome | 2005 |
12 other study(ies) available for misonidazole and fluorouracil
| Article | Year |
|---|---|
Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability.
Topics: Animals; Blood-Brain Barrier; Brain; Capillary Permeability; Male; Models, Biological; Molecular Weight; Rats; Rats, Inbred F344; Solubility; Structure-Activity Relationship | 1980 |
Effects of glutathione depletion using buthionine sulphoximine on the cytotoxicity in mammalian cells and human tumor cells in vitro.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Hypoxia; Cisplatin; Drug Synergism; Fluorouracil; Glutathione; Humans; Leukemia, Erythroblastic, Acute; Methionine Sulfoximine; Misonidazole; Stomach Neoplasms; Tumor Cells, Cultured | 1992 |
[The radiosensitizing effects of misonidazole and/or 5FU on C3H mouse mammary carcinoma].
Topics: Animals; Combined Modality Therapy; Female; Fluorouracil; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole | 1985 |
5-Fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea, misonidazole, and irradiation for brain stem gliomas: a pilot study of the Brain Tumor Research Center and the Childrens Cancer Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Cobalt Radioisotopes; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Fluorouracil; Glioblastoma; Glioma; Humans; Hydroxyurea; Lomustine; Male; Misonidazole; Prognosis; Radioisotope Teletherapy | 1984 |
Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans.
Topics: Adult; Aged; Drug Evaluation; Drug Synergism; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Kinetics; Male; Middle Aged; Misonidazole; Nausea; Nitroimidazoles; Time Factors; Vomiting | 1983 |
Simultaneous determination of some radiosensitizing and chemotherapeutic drugs in plasma by thin-layer chromatography.
Topics: Antineoplastic Agents; Chromatography, Thin Layer; Cyclophosphamide; Fluorouracil; Humans; Misonidazole; Radiation-Sensitizing Agents | 1983 |
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
Topics: Animals; Body Weight; Doxorubicin; Drug Therapy, Combination; Fibrosarcoma; Fluorouracil; Leukocyte Count; Male; Mammary Neoplasms, Experimental; Methotrexate; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1980 |
Targeting gene expression to hypoxic tumor cells.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Hypoxia; Cytosine Deaminase; DNA-Binding Proteins; Fibrosarcoma; Flucytosine; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nuclear Proteins; Nucleoside Deaminases; Oxygen; Phosphoglycerate Kinase; Prodrugs; Promoter Regions, Genetic; Recombinant Fusion Proteins; Transcription Factors; Tumor Cells, Cultured | 1997 |
Biological image-guided radiotherapy in rectal cancer: is there a role for FMISO or FLT, next to FDG?
Topics: Antimetabolites, Antineoplastic; Cell Hypoxia; Combined Modality Therapy; Dideoxynucleosides; Fluorodeoxyglucose F18; Fluorouracil; Humans; Misonidazole; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2008 |
Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Hypoxia; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Laryngeal Neoplasms; Middle Aged; Misonidazole; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Hydroxyurea; Middle Aged; Misonidazole; Neoplasm Staging; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2011 |
Baseline [(18)F]FMISO μPET as a Predictive Biomarker for Response to HIF-1α Inhibition Combined with 5-FU Chemotherapy in a Human Colorectal Cancer Xenograft Model.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Mice, Nude; Misonidazole; Positron-Emission Tomography; Reproducibility of Results; Xenograft Model Antitumor Assays | 2016 |